2009;104:671 7. 103. Calkins H, Yong P, Miller JM, et al. Catheter ablation of accessory path- ways, atrioventricular nodal reentrant tachycardia, and the atrioventricu- lar junction: final results of a prospective, multicenter clinical trial. The Atakr Multicenter Investigators Group. Circulation. 1999;99:262 70. 104. Scheinman MM, Huang S. The 1998 NASPE prospective catheter abla- tion registry. Pacing Clin Electrophysiol. 2000;23:1020 8. 105. Cheng CH, Sanders GD, Hlatky MA, et al. Cost-effectiveness of radio- frequency ablation for supraventricular tachycardia. Ann Intern Med. 2000;133:864 76. 106. Bohnen M, Stevenson WG, Tedrow UB, et al. Incidence and predictors of major complications from contemporary catheter ablation to treat cardiac arrhythmias. Heart Rhythm. 2011;8:1661 6. 107. Tendera M, Wnuk-Wojnar AM, Kulakowski P, et al. Efficacy and safety of dofetilide in the prevention of symptomatic episodes of paroxysmal supraventricular tachycardia: a 6-month double-blind comparison with propafenone and placebo. Am Heart J. 2001;142:93 8. 108. A randomized, placebo-controlled trial of propafenone in the pro- phylaxis of paroxysmal supraventricular tachycardia and paroxysmal atrial fibrillation. UK Propafenone PSVT Study Group. Circulation. 1995;92:2550 7. 109. Chimienti M, Cullen MT, Casadei G. Safety of flecainide versus propafenone for the long-term management of symptomatic paroxys- mal supraventricular tachyarrhythmias. Report from the Flecainide and Propafenone Italian Study (FAPIS) Group. Eur Heart J. 1995;16:1943 51. 110. Anderson JL, Platt ML, Guarnieri T, et al. Flecainide acetate for paroxys- mal supraventricular tachyarrhythmias. The Flecainide Supraventricular Tachycardia Study Group. Am J Cardiol. 1994;74:578 84. 111. Pritchett EL, DaTorre SD, Platt ML, et al. Flecainide acetate treatment of paroxysmal supraventricular tachycardia and paroxysmal atrial fibrilla- tion: dose-response studies. The Flecainide Supraventricular Tachycardia Study Group. J Am Coll Cardiol. 1991;17:297 303. 112. Pritchett EL, McCarthy EA, Wilkinson WE. Propafenone treatment of symptomatic paroxysmal supraventricular arrhythmias. A randomized, placebo-controlled, crossover trial in patients tolerating oral therapy. Ann Intern Med. 